Lipid Management
Understanding Your Lipid Panel: What Each Number Actually Tells You
Your lab report has 4-6 numbers on it. At least one of them is probably misleading you.
Written by the ArterAI team · Last reviewed April 2026
This content is for informational purposes only and does not constitute medical advice. Always consult your physician regarding your individual health decisions.
A lipid panel is a blood test that measures fats and fat-carrying proteins in your blood. It is the primary screening tool for cardiovascular risk, ordered as part of routine bloodwork. A common misconception: you do not necessarily need to fast for one. The 2016 European Atherosclerosis Society/European Federation of Clinical Chemistry joint statement found that non-fasting lipid panels are acceptable for routine screening, with fasting recommended only if triglycerides come back above 400 mg/dL. Many labs and doctors still default to fasting instructions, but the evidence has moved.
The standard panel reports total cholesterol, LDL, HDL, and triglycerides. Some include non-HDL cholesterol. Fewer include ApoB — which is a problem, because ApoB is arguably the most useful number on the entire panel. More on that in a moment.
The Number Your Panel Probably Does Not Include (But Should)
Apolipoprotein B — ApoB — counts the actual number of atherogenic (artery-clogging) particles in your blood. Every LDL particle, every VLDL particle, every IDL particle, and every Lp(a) particle has exactly one ApoB molecule on its surface. So ApoB gives you a direct particle count.
LDL-C (what your standard panel reports) measures the cholesterol content carried by LDL particles. But particles vary in size: some are large and cholesterol-rich, others are small and cholesterol-poor. Two people with identical LDL-C of 120 mg/dL can have wildly different numbers of actual particles — and it is the particle count that determines how many chances there are for one to penetrate the arterial wall and start a plaque.
This is not a fringe position. The evidence favoring ApoB over LDL-C as a risk predictor has been building for two decades. Mendelian randomization studies, prospective cohorts, and meta-analyses consistently show that ApoB is a stronger predictor of cardiovascular events than LDL-C. When the two disagree — called a discordant pattern — ApoB wins.
What “Discordant” Means in Practice
If your LDL-C is 110 mg/dL (looks fine) but your ApoB is 105 mg/dL (elevated), you have more atherogenic particles than your LDL number suggests. Your actual risk is closer to what the ApoB predicts. This pattern is common in people with insulin resistance, metabolic syndrome, or higher triglycerides — populations where small dense LDL particles predominate.
The reverse also happens: high LDL-C with low ApoB (fewer, larger particles). In that case, the LDL-C overstates risk. Either way, ApoB is the tiebreaker.
ApoB Reference Ranges:
- • Optimal: Below 80 mg/dL
- • Normal: Below 100 mg/dL
- • Borderline high: 100-120 mg/dL
- • High: Above 120 mg/dL
Ask your doctor to add ApoB to your next lipid panel. Most insurance covers it.
LDL Cholesterol — Useful, But Not the Whole Story
LDL-C is the number everyone fixates on, and it is not wrong to — it is directionally correct for most people. The causal relationship between LDL particles and atherosclerosis is about as well-established as anything in cardiology. More LDL particles penetrating the arterial endothelium means more plaque formation, more stenosis, more events.
LDL-C Reference Ranges:
- • Optimal: Below 100 mg/dL
- • Near optimal: 100-129 mg/dL
- • Borderline high: 130-159 mg/dL
- • High: 160-189 mg/dL
- • Very high: 190 mg/dL and above
Context matters more than the number alone. These ranges are population-level guidelines. A person with an LDL of 140 mg/dL and no other risk factors has a very different prognosis than a person with an LDL of 140 who also has diabetes, hypertension, and a family history of premature coronary disease. Risk stratification — using tools like the ASCVD risk calculator or, better yet, a frank conversation with a cardiologist — determines what your personal target should be. For people with established cardiovascular disease, many guidelines now push for LDL below 70 or even below 55 mg/dL.
HDL Cholesterol
HDL particles transport cholesterol from peripheral tissues back to the liver for processing — reverse cholesterol transport. Higher HDL has historically been associated with lower cardiovascular risk, which is why it earned the “good cholesterol” label.
But the story is more complicated than “higher is better.” Drugs that raised HDL (torcetrapib, dalcetrapib) failed to reduce cardiovascular events in clinical trials, which suggests that HDL level is a marker of metabolic health rather than a direct causal protector. The current thinking: low HDL signals risk, but artificially raising it does not fix the risk.
HDL Reference Ranges:
- • Low (higher risk): Below 40 mg/dL for men, below 50 mg/dL for women
- • Optimal: 60 mg/dL and above
Consistent exercise raises HDL by 3-9% over 8-12 weeks — the most effective non-pharmacological approach.
Triglycerides — The Most Diet-Responsive Number
Triglycerides respond faster to dietary changes than any other lipid marker. They spike after meals high in sugar, refined carbs, or alcohol, and drop noticeably within 2-4 weeks of reducing those inputs. If your panel was fasting, triglycerides reflect your baseline metabolic state. If it was non-fasting, expect them to run higher — a result above 400 mg/dL non-fasting warrants a follow-up fasting test.
Triglyceride Reference Ranges:
- • Optimal: Below 100 mg/dL
- • Normal: Below 150 mg/dL
- • Borderline high: 150-199 mg/dL
- • High: 200-499 mg/dL
- • Very high: 500 mg/dL and above (pancreatitis risk — needs prompt medical attention)
High triglycerides combined with low HDL is one of the most common dyslipidemia patterns and often signals insulin resistance or metabolic syndrome. Sugar and refined carb reduction is the first-line intervention.
Total Cholesterol and Non-HDL
Total cholesterol is the sum of everything — LDL + HDL + VLDL and others. Desirable is below 200 mg/dL. But this number can actively mislead: someone with very high HDL might show a total cholesterol of 240 mg/dL while having low actual risk. Doctors increasingly ignore total cholesterol in favor of the individual components.
Non-HDL cholesterol (total minus HDL) captures all atherogenic cholesterol — LDL, VLDL, IDL, and Lp(a). Target: below 130 mg/dL for most people. It is particularly useful when triglycerides are elevated, because high triglycerides make the standard LDL-C calculation (Friedewald equation) less reliable. Non-HDL does not have this problem, which is why some clinicians prefer it as a secondary target after ApoB.
Reading Your Results as a Pattern
No single number tells the full story. The clinical value is in the pattern — what the numbers say in combination, in the context of your personal history, family history, and other risk factors.
Common patterns and what they typically mean:
- High LDL-C + High ApoB: Concordant high-risk pattern. Both numbers agree — particle count is elevated. Lifestyle intervention first, medication if targets are not met.
- Normal LDL-C + High ApoB: Discordant — the LDL number is hiding elevated particle count. Common with insulin resistance and metabolic syndrome. ApoB is the more reliable indicator here.
- High triglycerides + Low HDL: Metabolic pattern. Often responds to sugar/carb reduction, exercise, and weight management before anything else.
- High LDL-C + Low ApoB: Discordant in the other direction — fewer, larger particles. LDL-C may be overstating actual risk. Still worth monitoring, but less alarming than the number suggests.
- Everything optimal: Maintenance mode. Sustain what you are doing, retest annually, and make sure ApoB stays concordant.
What to Do With Your Results
If ApoB was not on your panel, ask for it at your next draw. If Lp(a) has never been measured, get it done once — it is genetically determined and does not change, so a single test provides a lifetime data point.
Our cholesterol analysis tool takes your lipid panel numbers and identifies which patterns apply to your specific results. It takes under 2 minutes and provides evidence-based next steps.
Cholesterol is among the most modifiable risk factors for cardiovascular disease. The numbers on your lab report are a starting point — not a verdict.